Evaluatepharma subscription/license

Ended Purchase Order Awarded Last action

Contract number
FTC15H5143
Awardee
Awarding agency
Obligated
$122,601

Award facts

Opportunity
Contract value 100% obligated
$122,601.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Washington, DC 20530, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00004 · Evaluate pharma subscription $25,492
Exercise an Option P00003 $25,240
Exercise an Option 2 $24,745
Exercise an Option 1 $24,024
Original award $23,100

About this award

Written by GovTribe AI ·

This is a firm fixed-price purchase order issued by the Federal Trade Commission (FTC), a civilian federal agency, to Evaluate LIMITED, a foreign-owned for-profit organization, for a subscription/license to the EvaluatePharma product. The contract has a ceiling value of $122,601.00 and a period of performance ending on June 30, 2020. The contract was awarded on July 1, 2015 and was not set aside for any specific type of business. The FTC likely requires access to pharmaceutical market data and analysis to support its mission of promoting competition and protecting consumers.

Quick answers

Who was awarded contract FTC15H5143?

FTC15H5143 was awarded to Evaluate LIMITED by Federal Trade Commission on July 1, 2015.

How much is contract FTC15H5143 worth?

The government has obligated $122,601 on FTC15H5143.

Was contract FTC15H5143 competed?

The extent of competition for FTC15H5143 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login